Adam Asare, PhD

Adam L. Asare, PhD is the Director of Data Analysis for the Immune Tolerance Network (ITN), a clinical research consortium sponsored by NIAID/NIH and JDRF.  Dr. Asare has a Doctorate in Clinical Pathology, and completed a 4-year National Library of Medicine (NLM) fellowship in Biomedical Informatics focusing on data integration and analyses of specialty testing data.  His research interests include standardization and analysis of high dimensional data sets such as gene expression microarray and multicolor flow cytometry data, in a clinical trial setting.  His research group focuses on methods to correct for batch effects and technical artifacts in large longitudinal studies that are typically not addressed in most smaller scale settings but have significant impact in monitoring immune modulation.   He is one of the primary investigators in the development of a gene signature biomarker predicting tolerance in kidney transplant recipients and is in the process of validating a gene signature predicting conversion to Type I Diabetes Melitus from an ongoing natural history study.  Other research interests include automated quality assurance, gating and clustering approaches of flow cytometric data and multi-assay predictive modeling.  He is a strong proponent of reproducible, transparent research where data sets and open-source programmatic code can be disseminated to the research community for validation.